Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases

This publication has 94 references indexed in Scilit:

• Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase.
  Hypertension, 1994
• Age, endothelium and aortic reactivity to calcium in wistar rat
  Life Sciences, 1993
• Cytosolic and Sarcoplasmic Reticulum-Associated Low Km, cGMP-Inhibited cAMP Phosphodiesterase in Mammalian Myocardium
  Biochemical and Biophysical Research Communications, 1993
• Two Isoforms of cGMP-Inhibited Cyclic Nucleotide Phosphodiesterases in Human Tissues Distinguished by Their Responses to Vesnarinone, a New Cardiotonic Agent
  Biochemical and Biophysical Research Communications, 1993
• Current Status of Phosphodiesterase Inhibitors in the Treatment of Congestive Heart Failure
  Drugs, 1992
• Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury
  Biochemical and Biophysical Research Communications, 1992
• Subclasses of cyclic GMP-specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor.
  Hypertension, 1990
• Differential sensitivity of arachidonic acid release and 1,2-diacylglycerol formation to pertussis toxin, GDP βS and NaF in saponin-permeabilized human platelets: possible evidence for distinct GTP-binding proteins involving phospholipase C and A2 activation
  Biochemical and Biophysical Research Communications, 1987
• Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity
  Biochemical and Biophysical Research Communications, 1983
• HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro
  Life Sciences, 1982